UBX - Unity Biotechnology, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/2016
Total Revenue-1,382-
Cost of Revenue58,90737,37313,707
Gross Profit-58,907-35,991-13,707
Operating Expenses
Research Development---
Selling General and Administrative16,0169,6175,137
Non Recurring---
Others---
Total Operating Expenses74,92346,99018,844
Operating Income or Loss-74,923-45,608-18,844
Income from Continuing Operations
Total Other Income/Expenses Net-1,475952-11,560
Earnings Before Interest and Taxes-74,923-45,608-18,844
Interest Expense---2,183
Income Before Tax-76,398-44,656-30,404
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-76,398-44,656-30,404
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-76,398-44,656-30,404
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-76,398-44,656-30,404